November 7, 2011
Ono Pharmaceutical reported sales of ¥70.17 billion (+10.0% over the corresponding period of the previous year) in its consolidated settlement of accounts for April-September 2011. Growth in sales was driven by Glactiv Tablets (sitagliptin), a dipeptidyl peptidase-4 (DPP-4) inhibitor for...read more